Occudo Quantitative Strategies LP Recursion Pharmaceuticals, Inc. Transaction History

Occudo Quantitative Strategies LP

  • $501 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$6.42 - $9.64 $205,292 - $308,258
31,977 New
31,977 $213,000
Q3 2022

Nov 14, 2022
SELL
$7.83 - $13.6 $366,569 - $636,697
-46,816 Reduced 48.88%
48,971 $521,000
Q2 2022

Aug 15, 2022
SELL
$5.04 - $9.26 $120,753 - $221,860
-23,959 Reduced 20.01%
95,787 $780,000
Q1 2022

May 16, 2022
BUY
$6.16 - $18.03 $737,635 - $2.16 Million
119,746 New
119,746 $857,000

Others Institutions Holding RXRX

# of Institutions
286
Shares Held
242M
Call Options Held
1.35M
Put Options Held
2.32M
View Full List

About RECURSION PHARMACEUTICALS, INC.

RXRX Quotes by TradingView
  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $1.41B
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email